Inventors at heart, our international team leverages our diverse backgrounds to solve real world problems in medical practice – from clinical and research leadership to a broad range of product and service design applications.
Chief Executive Officer
Eliott leads Biospectal’s strategic direction as well as product vision and execution. A digital innovator and startup veteran, Eliott is responsible for guiding high level strategy, market development, and product direction.
Eliott’s digital career started in the beginnings of the Web while working in the systems integration and strategic technology consulting industry. He was immediately captivated by the potential of this transformative new era of technology to enhance the human experience, and he has since remained on the forefront of exploring and applying new technology in the human context.
Eliott has held executive roles building digital innovation organizations and driving strategy, digital product design and development for major brands including Yahoo, Landor Associates/Young & Rubicam, Intuit, Logitech and Rambus. In addition to advising early stage startups, he is also a mentor in Colgate University’s Thought in Action Institute, helping young entrepreneurs to hone their business ideas and to bring their product visions to fruition.
Eliott holds a degree in Visual and Environmental Studies, Magna Cum Laude, from Harvard, where he also served as teaching faculty in design.
Prof. Patrick Schoettker
Chief Medical Officer
Dr. Schoettker is the original spark for Biospectal’s vision to become a revolutionary force in how we measure and manage patient outcomes through merging breakthrough optical biosensing technology with ubiquitous IoT devices. Dr. Schoettker is a professor specializing in Anesthesiology and Emergency medicine at CHUV and actively partners with CSEM to introduce and validate new medical technologies in the clinical setting in Lausanne. His focus of interest is bringing technology into the patient care setting in order to improve medical outcomes through improved efficacy, as well as better patient centered care factors relating to ease of use and comfort.
To support Biospectal’s imperative of achieving medical grade accuracy, Patrick plays a critical role to ensure that data acquired through innovative technology has been validated scientifically in a medical environment.
Prior to his tenure at CHUV, where Dr. Schoettker rose to Head Physician in the Department of Anesthesiology of the Lausanne University Hospital, his medical training spanned the globe, taking him to France, Canada and Australia. In the process, he explored varying medical perspectives and practice methods across diverse academic and clinical environments. These experiences have proven a continuing influence in his boundary stretching outlook and human centered approach to medicine.
Dr. Schoettker is the author of more than forty scientific papers and editor of a best-selling medical textbook. He also claims numerous patents and inventions in the field of anesthesia, acute care medicine and wireless physiological signals acquisition and monitoring.
Chief Financial Officer
Thierry leads Biospectal’s finance and business operations. With ten years’ experience in the banking services sector, he is also a serial entrepreneur in the field of innovative textile design and creation.
Thierry claims a strong background in maximizing investment return and has acted as a leader in international small businesses in the field of technology transfer to final user. His broad network of clients and investors encompasses Europe, United-States and Australasia.
Through his success in combining of financial acumen and passion for non-traditional startup innovation, Thierry demonstrates an “out-of-the-box” approach to human networking, financial intuition and go-to-market solutions.
Chief Technology/Ops Officer
With more than twenty-five years in launching and managing technology-based start-ups, Peter has extensive experience in leading and managing large, complex systems development projects.
As CEO of Thaumaturgix, Peter’s role included substantial business operations, corporate development, finance, legal, and product lifecycle management. His firm was twice ranked in the Inc. 500 Fastest Growing Private Companies list. Peter was also an early employee of Cambridge Technology Group/Partners, which became a global consultancy.
Peter has sat on several boards of technology innovation companies including AmericanDiamondMint (e-commerce), Port Indigo (mobile solutions), UnChat LLC (online democracy platform), Transclick (wireless multi-lingual translation), CheetahMail (email marketing), and Intellireach Infocrossing (IT outsourcing).
Several of the startups with which he has been involved have had successful exits, from sales netting investors over 10+ times returns to IPO.
Peter holds a B.S. in Management Science from M.I.T.